Dimitri P Mikhailidis Selected Research

Transient Ischemic Attack

7/2022	Benefits and drawbacks of statins and non-statin lipid lowering agents in carotid artery disease.
4/2022	Optimal management of asymptomatic carotid stenosis in 2021: the jury is still out. An international, multispecialty, expert review and position statement.
1/2022	Optimal Management of Asymptomatic Carotid Stenosis in 2021: The Jury is Still Out. An International, Multispecialty, Expert Review and Position Statement.
5/2021	Management of Patients with Asymptomatic Carotid Stenosis May Need to Be Individualized: A Multidisciplinary Call for Action.
1/2017	Pioglitazone in patients with insulin resistance after ischemic stroke or transient ischemic attack: A comment on the IRIS trial.
8/2012	Local versus general anesthesia for carotid endarterectomy: issues beyond stroke, myocardial infarction, and death rates.
1/2007	Emerging indications for statins: a pluripotent family of agents with several potential applications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dimitri P Mikhailidis Research Topics

Disease

69	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 05/2002
47	Hypertension (High Blood Pressure) 01/2022 - 01/2002
47	Coronary Disease (Coronary Heart Disease) 12/2020 - 01/2002
44	Atherosclerosis 01/2022 - 01/2002
43	Stroke (Strokes) 11/2022 - 01/2003
43	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 01/2005
41	Inflammation (Inflammations) 01/2022 - 03/2006
39	Non-alcoholic Fatty Liver Disease 01/2022 - 05/2006
32	Obesity 01/2021 - 08/2005
32	Dyslipidemias (Dyslipidemia) 01/2020 - 05/2002
29	Type 2 Diabetes Mellitus (MODY) 12/2020 - 09/2003
28	Heart Failure 01/2022 - 03/2006
28	Insulin Resistance 01/2021 - 09/2003
28	Vascular Diseases (Vascular Disease) 07/2018 - 01/2003
24	Chronic Renal Insufficiency 01/2020 - 05/2009
22	Peripheral Arterial Disease 01/2022 - 04/2003
19	Diabetes Mellitus 01/2022 - 01/2003
17	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2003
17	Body Weight (Weight, Body) 12/2020 - 01/2004
16	Myocardial Infarction 07/2022 - 01/2003
15	Carotid Stenosis (Carotid Artery Stenosis) 07/2022 - 03/2007
14	Neoplasms (Cancer) 01/2020 - 10/2006
13	Acute Coronary Syndrome 01/2021 - 01/2005
12	Hypercholesterolemia 01/2021 - 10/2002
11	Hyperlipidemias (Hyperlipidemia) 01/2018 - 09/2006
10	Abdominal Aortic Aneurysm 07/2018 - 08/2007
9	Carotid Artery Diseases 07/2022 - 08/2007
9	Thrombosis (Thrombus) 07/2018 - 01/2005
8	Fatty Liver 01/2022 - 12/2011
8	Erectile Dysfunction 01/2022 - 01/2002
8	Ischemic Stroke 01/2022 - 01/2003
8	Atherosclerotic Plaque (Atheroma) 01/2015 - 01/2003
7	Transient Ischemic Attack 07/2022 - 01/2007
7	Hemorrhage 04/2022 - 02/2006
7	Atrial Fibrillation 01/2022 - 03/2006
7	Abdominal Obesity 11/2017 - 07/2005
7	Alcoholic Fatty Liver 01/2017 - 08/2012
6	Essential Hypertension 02/2014 - 04/2005
6	Hypertriglyceridemia 01/2012 - 09/2003
5	Unstable Angina 01/2021 - 11/2007
5	Weight Loss (Weight Reduction) 01/2020 - 05/2007
5	Acute Kidney Injury (Acute Renal Failure) 01/2018 - 01/2008
5	Ischemia 03/2010 - 01/2006
5	Prostatic Neoplasms (Prostate Cancer) 01/2010 - 09/2004

Drug/Important Bio-Agent (IBA)

130	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2022 - 07/2002
75	LipidsIBA 07/2022 - 01/2002
36	Triglycerides (Triacylglycerol)IBA 12/2020 - 10/2002
33	Atorvastatin (Lipitor)FDA Link 01/2014 - 01/2002
30	CholesterolIBA 11/2021 - 04/2004
27	oxidized low density lipoproteinIBA 07/2022 - 01/2002
26	HDL CholesterolIBA 01/2019 - 01/2002
23	Uric Acid (Urate)IBA 09/2021 - 04/2004
22	LDL CholesterolIBA 07/2022 - 01/2002
22	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 07/2005
21	C-Reactive ProteinIBA 01/2022 - 05/2002
18	Ezetimibe (Zetia)FDA Link 07/2022 - 10/2006
17	Pharmaceutical PreparationsIBA 01/2021 - 08/2005
14	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2006
12	Lipoprotein(a)IBA 01/2022 - 07/2005
12	Insulin (Novolin)FDA Link 01/2018 - 01/2008
11	Lipoproteins (Lipoprotein)IBA 01/2021 - 01/2005
11	ApolipoproteinsIBA 01/2020 - 01/2003
9	Simvastatin (Zocor)FDA LinkGeneric 01/2021 - 01/2003
9	AdipokinesIBA 01/2021 - 12/2007
9	Fibrinogen (Factor I)FDA Link 02/2019 - 09/2003
9	AntioxidantsIBA 12/2018 - 01/2006
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2009
8	Hypoglycemic Agents (Hypoglycemics)IBA 11/2021 - 08/2010
8	Vitamin D FDA LinkGeneric 05/2019 - 10/2010
8	LeptinIBA 07/2018 - 06/2006
8	Rosuvastatin Calcium (Crestor)FDA Link 07/2015 - 06/2006
7	Indicators and Reagents (Reagents)IBA 07/2016 - 06/2002
7	HDL LipoproteinsIBA 01/2016 - 07/2005
7	LDL Lipoproteins (beta Lipoproteins)IBA 01/2014 - 01/2007
6	CreatinineIBA 12/2022 - 10/2008
6	Fibric Acids (Fibrates)IBA 07/2022 - 01/2009
6	Clopidogrel (Plavix)FDA Link 01/2022 - 04/2003
6	AdiponectinIBA 08/2017 - 05/2007
6	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2014 - 03/2004
6	Fenofibrate (CiL)FDA LinkGeneric 12/2013 - 01/2005
6	Serotonin (5 Hydroxytryptamine)IBA 05/2013 - 11/2005
6	Adenosine Triphosphate (ATP)IBA 01/2012 - 01/2005
6	Antihypertensive Agents (Antihypertensives)IBA 07/2011 - 01/2002
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 03/2004
5	CytokinesIBA 01/2021 - 07/2013
5	Blood Glucose (Blood Sugar)IBA 01/2019 - 11/2005
5	BilirubinIBA 05/2016 - 02/2009
5	GhrelinIBA 04/2013 - 01/2011
5	Hormones (Hormone)IBA 04/2013 - 09/2004
5	Metformin (Glucophage)FDA LinkGeneric 01/2012 - 05/2006
5	Orlistat (Xenical)FDA Link 11/2011 - 05/2006
5	Apolipoproteins E (ApoE)IBA 01/2009 - 01/2003
4	AlbuminsIBA 01/2022 - 01/2013

Therapy/Procedure

52	Therapeutics 01/2022 - 05/2002
12	Carotid Endarterectomy 11/2022 - 03/2007
10	Secondary Prevention 09/2021 - 05/2005
10	Percutaneous Coronary Intervention 01/2019 - 02/2006
8	Glycemic Control 01/2020 - 05/2007
7	Drug Therapy (Chemotherapy) 01/2020 - 08/2009
6	Vascular Surgical Procedures 11/2022 - 09/2010